Skip to content

Georgia McCaughan

Dr Georgia McCaughan is a Clinical and Laboratory Haematologist, and the Head of the Multiple Myeloma and AL amyloidosis Laboratory within the Haematology AMR Research Program at St Vincent’s Centre for Applied Medical Research.

Bio

Dr Georgia McCaughan is a Clinical and Laboratory Haematologist, and the Head of the Multiple Myeloma and AL amyloidosis Laboratory within the Haematology AMR Research Program at St Vincent’s Centre for Applied Medical Research. She is devoted to the care and management of patients with these diseases. She is the chair of the Myeloma Working Group of the Australian Leukaemia and Lymphoma Group (ALLG), a steering committee member of The Australasian Myeloma Research Consortium (AMaRC) and a member of the Medical and Scientific Advisory Group to Myeloma Australia. Dr McCaughan is a Senior Research Associate with the University of New South Wales and Garvan Institute of Medical Research.

PublicationsSelected Publications from Georgia McCaughan

  • Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations. Gorrie N, Geenty P, Rye E, et al. NPJ Cardiovasc Health. 2025; 2,1-10.
  • Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry. Irving A, Petrie D, Harris A, et al. PLoS One. 2024; 19(8):e0308812. PMID: 39190684.
  • Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. Hoff FW, Banerjee R, Khan AM, et al. Blood Cancer J. 2024; 14(1):52. PMID: 38519476.
  • Lenalidomide, bortezomib and dexamethasone induction therapy for treatment of newly diagnosed multiple myeloma: a practical review. McCaughan GJ, Gandolfi S, Moore JJ, et al. British Journal of Haematology. 2022; 199(2):190-204. PMID: 35796524.
  • Development of CAR T-cell lymphoma in two of ten patients effectively treated with piggyBac modified CD19 CAR T-cells. Bishop DC, Clancy LE, Simms R, et al. Blood. 2021; 138(16):1504-1509. PMID: 34010392.